Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Porcine skin is very similar to human skin, making it a useful model for research.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

The conclusion is that a team of skin doctors and psychiatrists is needed to better treat patients with mind-skin disorders.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Imbalance in scalp bacteria can affect hair and scalp health, potentially leading to conditions like hair loss, psoriasis, and dandruff.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Lowest effective minoxidil concentration is 1%, but 2% works better for male pattern baldness.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Niosomes can effectively deliver Superoxide Dismutase to hair follicles, potentially helping prevent hair loss.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.